Literature DB >> 18985369

Occult metastases from T1-T2 supraglottic carcinoma: role of primary tumor localization.

Imdat Yüce1, Sedat Cağli, Ali Bayram, Ercihan Güney.   

Abstract

The present study was undertaken to evaluate the role of localization on the rate of occult metastasis in early stage supraglottic laryngeal carcinoma. We selected carefully 32 T1-2 clinically N0 patients without epilarynx involvement and 39 T1-2 clinically N0 patients with epilarynx involvement from among patients with supraglottic laryngeal carcinoma. All patients underwent simultaneous unilateral or bilateral neck dissection with laryngeal surgery. The rate of the occult metastases was 3.1% in patients without epilarynx involvement, whereas it was 20.5% in patients with epilarynx involvement. Within the supraglottic larynx, two subregions can be distinguished: the epilarynx and the lower supraglottis. Our results suggest the possibility of omitting elective neck treatment in T1-2N0 supraglottic laryngeal carcinoma without epilarynx involvement. Observation under strict follow-up may be an option to routine neck treatment in T1-2N0 supraglottic laryngeal carcinoma without epilarynx involvement.

Entities:  

Mesh:

Year:  2008        PMID: 18985369     DOI: 10.1007/s00405-008-0859-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Lymphatic metastasis to the supraretrospinal recess in laryngeal squamous cell carcinoma.

Authors:  Ahmet Koybasioğlu; Sabri Uslu; Metin Yilmaz; Erdoğan Inal; Fikret Ileri; Korhan Asal
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-01       Impact factor: 1.547

2.  Is routine inclusion of level IV necessary in neck dissection for clinically N0 supraglottic carcinoma?

Authors:  Sedat Cağli; Imdat Yüce; Ercihan Güney
Journal:  Otolaryngol Head Neck Surg       Date:  2007-02       Impact factor: 3.497

3.  Oncological and functional outcome of conservative surgery for primary supraglottic cancer.

Authors:  M Maurizi; G Paludetti; J Galli; F Ottaviani; G D'Abramo; G Almadori
Journal:  Eur Arch Otorhinolaryngol       Date:  1999       Impact factor: 2.503

4.  Treatment of the clinically negative neck in laryngeal cancer patients.

Authors:  O Gallo; V Boddi; G V Bottai; F Parrella; O F Storchi
Journal:  Head Neck       Date:  1996 Nov-Dec       Impact factor: 3.147

5.  Supraglottic laryngeal cancer: analysis of treatment results.

Authors:  Donald G Sessions; Jason Lenox; Gershon J Spector
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

6.  Epilarynx: pharynx or larynx?

Authors:  J L Lefebvre; E Buisset; B Coche-Dequeant; J T Van; B Prevost; B Hecquet; A Demaille
Journal:  Head Neck       Date:  1995 Sep-Oct       Impact factor: 3.147

7.  The N0 neck in head and neck cancer patients.

Authors: 
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Management of cancer of the supraglottis.

Authors:  B Scola; M Fernández-Vega; T Martínez; S Fernández-Vega; C Ramirez
Journal:  Otolaryngol Head Neck Surg       Date:  2001-02       Impact factor: 3.497

9.  Laryngeal spaces and lymphatics: current anatomic concepts.

Authors:  L W Welsh; J J Welsh; T A Rizzo
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1983 Jul-Aug

Review 10.  Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: a systematic review.

Authors:  J K Goudakos; K Markou; A Nikolaou; C Themelis; V Vital
Journal:  Eur J Surg Oncol       Date:  2008-05-12       Impact factor: 4.424

View more
  3 in total

1.  Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

Authors:  E Fountzilas; K Markou; K Vlachtsis; A Nikolaou; P Arapantoni-Dadioti; E Ntoula; G Tassopoulos; M Bobos; P Konstantinopoulos; G Fountzilas; D Spentzos
Journal:  Ann Oncol       Date:  2012-01-04       Impact factor: 32.976

2.  Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.

Authors:  Zhendong Yang; Jinxin Wang; Chun Chen; Peng Sun; Yafeng Yu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

3.  Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer.

Authors:  Giovanni Salzano; Francesco Perri; Fabio Maglitto; Giulia Togo; Gianluca Renato De Fazio; Michela Apolito; Federica Calabria; Claudia Laface; Luigi Angelo Vaira; Umberto Committeri; Mario Balia; Ettore Pavone; Corrado Aversa; Francesco Antonio Salzano; Vincenzo Abbate; Alessandro Ottaiano; Marco Cascella; Mariachiara Santorsola; Roberta Fusco; Luigi Califano; Franco Ionna
Journal:  J Pers Med       Date:  2021-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.